A noninvasive method in the differential diagnosis of vecuronium- induced and magnesium-induced protracted neuromuscular block in a severely preeclamptic patient

Journal of Clinical Anesthesia

Volumn 8, Issue 5, 1996, Pages 392-397

  Kwan, Wing Fai ^a   Lee, Chingmuh ^a   Chen, Biing Jaw ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Anesthesia, obstetric; ion, magnesium; neuromuscular blockade, potentiation; neuromuscular relaxant, vecuronium; neuromuscular transmission, refractoriness

Indexed keywords

ATROPINE; DEXAMETHASONE; EDROPHONIUM; HYDRALAZINE; MAGNESIUM ION; MAGNESIUM SULFATE; MUSCLE RELAXANT AGENT; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; OXYTOCIN; SUXAMETHONIUM; THIOPENTAL; TRIMETAPHAN; VECURONIUM;

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DRUG POTENTIATION; ELECTROMYOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAGNESIUM BLOOD LEVEL; MATERNAL HYPERTENSION; NEUROMUSCULAR BLOCKING; OBSTETRIC ANESTHESIA; PREECLAMPSIA; PRIORITY JOURNAL;

EID: 0030222287     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/0952-8180(96)00087-6     Document Type: Article

References (19)

1. 1. Morris R, Giesecke AH: Potentiation of muscle relaxants by magnesium sulfate therapy in toxemia of pregnancy. So Med J 1968; 61:25-8.
2. 2. Skaredoff MN, Roaf ER, Datta S: Hypermagnesaemia and anaesthetic management. Can Anaesth Soc J 1982;29:35-41.
3. 3. Baraka A, Yazigi A: Neuromuscular interaction of magnesium with succinylcholine-vecuronium sequence in the eclamptic parturient. Anesthesiology 1987;67:806-8.
4. 4. Lee CM: Train-of-four quantitation of competitive neuromuscular block. Anesth Analg 1975;54:649-53.
5. 5. Lee C, Katz RL, Lee AS, Glaser B: A new instrument for continuous recording of the evoked compound electromyogram in the clinical setting. Anesth Analg 1977;56;260-70.
6. 6. Epstein RA, Jackson SH, Wyte SR: The effects of nondepolarizing relaxants and anticholinesterases on the neuromuscular refractory period of anesthetized man. Anesthesiology 1969;31:69-77.
7. 7. James MF, Cork RC, Dennett JE: Succinylcholine pretreatment with magnesium sulfate. Anesth Analg 1986;65:373-6.
8. 8. Sinatra RS, Philip BK, Naulty JS, Ostheimer GW: Prolonged neuromuscular blockade with vecuronium in a patient treated with magnesium sulfate. Anesth Analg 1985;64:1220-2.
9. 9. Rupp SM, Miller RD, Gencarelli PJ: Vecuronium-induced neuromuscular blockade during enflurane, isoflurane, and halothane anesthesia in humans. Anesthesiology 1984;60:102-5.
10. 10. Wilson SL, Miller RN, Wright C, Hasse D: Prolonged neuromuscular blockade associated with trimethaphan: a case report. Anesth Analg 1976;55:353-6.
11. 11. Feldman SA: Effect of changes in electrolytes, hydration and pH upon the reactions to muscle relaxants. Br J Anaesth 1963;35:546-51.
12. 12. Bencini AF, Houwertjes MC, Agoston S: Effects of hepatic uptake of vecuronium bromide and its putative metabolites on their neuromuscular blocking actions in the cat. Br J Anaesth 1985;57:789-95.
13. 13. Bencini AF, Scaf AH, Sohn YJ, Kersten-Kleef UW, Agoston S: Hepatobiliary disposition of vecuronium bromide in man. Br J Anaesth 1986;58:988-95.
14. 14. Hunter JM, Jones RS, Utting JE: Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function. Br J Anaesth 1984;56:941-51.
15. 28*. J Clin Invest 1960;38:420-5.
16. 16. Ramanathan J, Sibai BM, Pillai R, Angel JJ: Neuromuscular transmission studies in preeclamptic women receiving magnesium sulfate. Am J Obstet Gynecol 1988;158:40-6.
17. 17. del Castillo J, Engbaek L: The nature of the neuromuscular block produced by magnesium. J Physiol 1954;124:370-84.
18. 18. Ghoneim MM, Long JP: The interaction between magnesium and other neuromuscular blocking agents. Anesthesiology 1970;32: 23-7.
19. 19. Gutschi B, Cheek T: Anesthesia considerations in preeclampsia-eclampsia. In: Shnider SM, Levinson GT (eds): Anesthesia for Obstetrics, 3rd ed. Baltimore: Williams and Wilkins, 1993:316.